CHMP mente dog, at kun non- selektive irreversible MAO - hæmmere skal være kontraindicerede, og at en kraftig advarsel i afsnit 4. 4 og afsnit 4. 5 i
With regards to cardiovascular safety, it was agreed that a contraindication was not warranted and that a revised wording for Section 4.4 was sufficient.